Invoking ‘Choice’ When Discussing Surrogacy as a Feminist Concern is a Mistake
By Susan Berke Fogel, Francine Coeytaux, Marcy Darnovsky, Lisa Ikemoto, and Judy Norsigian,
RH Reality Check
| 04. 23. 2014
It is troubling to see the vexing question of
commercial surrogacy treated as a litmus test for feminists at
RH Reality Check. While some lifelong supporters of women’s rights may see nothing problematic about contract pregnancy, others argue that it should be prohibited, and still others believe it should be allowed but
carefully regulated. Contract pregnancy can’t be understood in a simplistic
pro-choice versus anti-choice framework, or as only a matter of self-determination. Thirty years after “Baby M” and more than a decade after the emergence of a cross-border surrogacy industry, some of us are still unsure where we come down on commercial surrogacy. But it seems indisputable that the issue of contract pregnancy deserves careful thought.
We at the Pro-Choice Alliance for Responsible Research believe that social justice, safety, and human rights must be paramount in public policy and private practice in emerging biotechnologies, and we are striving to assess commercial surrogacy from that perspective. The surrounding quandaries are many and complex, especially for women working as surrogates and the children they bear, but also for commissioning...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...